Neuralink Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 440

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $323M

  • Investors
  • 36

Neuralink General Information

Description

Developer of an implantable brain-machine interface designed to help people with paralysis. The company's interface is designed to treat and diagnose neurological conditions in humans and conceivably augment human cognitive powers, enabling doctors to treat serious brain diseases in the short term.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 7400 Paseo Padre Parkway
  • Fremont, CA 94555
  • United States
+1 (650) 000-0000

Neuralink Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neuralink Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series D) 22-Nov-2023 $323M 00000 00.000 Completed Clinical Trials - General
4. Later Stage VC (Series C) 30-Jul-2021 00000 00000 00.000 Completed Clinical Trials - General
3. Early Stage VC (Series B) 28-Jun-2019 0000 00000 00000 Completed Clinical Trials - General
2. Accelerator/Incubator 09-Apr-2019 $107M Completed Clinical Trials - General
1. Early Stage VC 24-Aug-2017 $107M $107M Completed Clinical Trials - General
To view Neuralink’s complete valuation and funding history, request access »

Neuralink Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 00,000,000 00.000000 00.00 000.00 000.00 00 000.00 0.000
Series C 00,000,000 00.000000 00.00 000.00 000.00 00 000.00 0.000
Series B-1 00,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series B 13,391,700 $0.001000 $0.19 $3.82 $3.82 1x $3.82 7.23%
Series A 107,000,000 $0.001000 $0.05 $1 $1 1x $1 57.79%
To view Neuralink’s complete cap table history, request access »

Neuralink Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an implantable brain-machine interface designed to help people with paralysis. The company's interface is d
Therapeutic Devices
Fremont, CA
440 As of 2024
00000
00.000 0000-00-00
00000000000 00000

000000

d tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, q
00000000000 0000000
New York, NY
00 As of 0000
0000
00000000000 0000

000000

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea co
0000000000 000000000
Los Angeles, CA
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neuralink Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Precision Neuroscience Venture Capital-Backed New York, NY 00 0000 00000000000 0000
Kernel Venture Capital-Backed Los Angeles, CA 00 000.00 0000000000 0 000.00
BrainGate Venture Capital-Backed Providence, RI 00000000000
AliveCor Venture Capital-Backed Mountain View, CA 000 00000 0000 00000
Mainstay Medical Venture Capital-Backed San Diego, CA 000 00000 0000000000 0 00000
You’re viewing 5 of 10 competitors. Get the full list »

Neuralink Patents

Neuralink Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240232340-A1 Out-of-band pairing for wireless neural implant Pending 11-Jan-2023 0000000000
US-20240128222-A1 Die reconstitution and high-density interconnects for embedded chips Pending 18-Oct-2022 000000000
US-20230382098-A1 Dicing and partial dicing release of lithographed device Pending 31-May-2022 00000000000
US-20230310028-A1 Cannula for grasping and setting lead with needle Pending 01-Apr-2022 00000000000
US-20230284982-A1 Neural signal compression for brain-machine interface Pending 09-Mar-2022 A61B5/725
To view Neuralink’s complete patent history, request access »

Neuralink Executive Team (13)

Name Title Board Seat Contact Info
Kate Ianishevska Co-Chief Executive Officer
Shivon Zilis Director of Operations and Special Projects
Dongjin Seo Co-Founder & Vice President of Engineering
Lisa Li Co-Founder
Elon Musk Co-Founder & Co-Chief Executive Officer
You’re viewing 5 of 13 executive team members. Get the full list »

Neuralink Board Members (1)

Name Representing Role Since
Jared Birchall Self Co-Chief Executive Officer, Chief Financial Officer & Board Member 000 0000
To view Neuralink’s complete board members history, request access »

Neuralink Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neuralink Investors (36)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Advaita Capital Venture Capital Minority 000 0000 000000 0
Calm Ventures Venture Capital Minority 000 0000 000000 0
Capital Advantage Ventures Hedge Fund Minority 000 0000 000000 0
E1 Ventures Venture Capital Minority 000 0000 000000 0
East River Venture Partners Growth/Expansion Minority 000 0000 000000 0
You’re viewing 5 of 36 investors. Get the full list »

Neuralink FAQs

  • When was Neuralink founded?

    Neuralink was founded in 2016.

  • Who is the founder of Neuralink?

    Dongjin Seo, Lisa Li, Philip Sabes, Vanessa Tolosa, Elon Musk, Max Hodak, Tim Hanson, Benjamin Rapoport Ph.D, Paul Merolla Ph.D, and Tim Gardner Ph.D are the founders of Neuralink.

  • Who is the CEO of Neuralink?

    Kate Ianishevska, Elon Musk, and Jared Birchall are the CEOs of Neuralink.

  • Where is Neuralink headquartered?

    Neuralink is headquartered in Fremont, CA.

  • What is the size of Neuralink?

    Neuralink has 440 total employees.

  • What industry is Neuralink in?

    Neuralink’s primary industry is Therapeutic Devices.

  • Is Neuralink a private or public company?

    Neuralink is a Private company.

  • What is the current valuation of Neuralink?

    The current valuation of Neuralink is 00.000.

  • What is Neuralink’s current revenue?

    The current revenue for Neuralink is 00000.

  • How much funding has Neuralink raised over time?

    Neuralink has raised $687M.

  • Who are Neuralink’s investors?

    Advaita Capital, Calm Ventures, Capital Advantage Ventures, E1 Ventures, and East River Venture Partners are 5 of 36 investors who have invested in Neuralink.

  • Who are Neuralink’s competitors?

    Precision Neuroscience, Kernel, BrainGate, AliveCor, and Mainstay Medical are some of the 10 competitors of Neuralink.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »